LQDA
Liquidia Corp Health Care Pharmaceutical Preparations Russell 3000
$45.06Close
$3.9BMarket cap
$23.20 – $91.0352-week range
Nov 2, 2026Next report
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Far from its high 50% below its 52-week high
- Results soon Nov 2, 2026, in 1 day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
50%
1wk
up 5.7%
price change
1mo
up 48.9%
price change
12-month return
up 94%
market up 11% ·
its own up 90%
F-score
—
— Not assessed
Altman Z
6.12
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
87.8×
price / book
Earnings yield
down 1.4%
EBIT / enterprise value
Cheaper than
14%
of the market · expensive
Revenue growth
up 1031%
year on year
EPS growth
—
latest quarter
Sales growth
up 1843%
latest quarter · -2316 pts
ROE
down 111%
return on equity
Free cash margin
down 25%
-$40.0M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Revenue reaccelerating (-20% then +1031%)
Trade setup
ATR%
8.4%
$3.78 a day · 2×ATR $37.49
RS
56 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
0.5×
vs 50-day average
Up/down volume
0.96
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 3 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 3.0% over the year, from 85m to 87m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 12, 2026
Last shock
Sep 30, 2026-57% in one session12.4× volumeon an SEC filing+49% since
Financials
- Gross
- Net -44%
- Free cash -25%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $739,628 | $12.9M | $15.9M | $17.5M | $14.0M | $158.3M |
| Gross margin | 68% | 76% | 82% | 83% | 58% | — |
| Operating income | -$59.1M | -$33.8M | -$38.8M | -$73.4M | -$121.3M | -$51.4M |
| Net income | -$59.8M | -$34.6M | -$41.0M | -$78.5M | -$130.4M | -$68.9M |
| Net margin | -8080% | -269% | -257% | -449% | -932% | -44% |
| Earnings per share | -$1.76 | -$0.70 | -$0.67 | -$1.21 | -$1.66 | -$0.80 |
| Free cash flow | -$54.9M | -$34.1M | -$29.2M | -$42.9M | -$98.4M | -$40.0M |
| Free cash margin | -7422% | -266% | -183% | -245% | -703% | -25% |
| Cash | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | $190.7M |
| Long-term debt | $10.3M | $10.4M | $19.9M | — | — | — |
| Shareholders' equity | $71.1M | $65.3M | $90.4M | $47.3M | $79.4M | $44.7M |
| Shares outstanding | 43.34m | 52.29m | 64.52m | 68.63m | 84.68m | 87.20m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 12, 2026 | Quarterly ↗ | Jun 30, 2026 | 43d |
| May 11, 2026 | Quarterly ↗ | Mar 31, 2026 | 41d |
| Mar 5, 2026 | Annual ↗ | Dec 31, 2025 | 64d |
| Nov 3, 2025 | Quarterly ↗ | Sep 30, 2025 | 34d |
| Aug 12, 2025 | Quarterly ↗ | Jun 30, 2025 | 43d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Mar 19, 2025 | Annual ↗ | Dec 31, 2024 | 78d |
| Nov 13, 2024 | Quarterly ↗ | Sep 30, 2024 | 44d |
| Aug 7, 2024 | Quarterly ↗ | Jun 30, 2024 | 38d |
| May 13, 2024 | Quarterly ↗ | Mar 31, 2024 | 43d |
| Mar 13, 2024 | Annual ↗ | Dec 31, 2023 | 73d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 14, 2026 | Material agreement · Agreement ended · Regulation FD · Other events ↗ |
| Sep 30, 2026 | Other events ↗ |
| Sep 3, 2026 | Other events ↗ |
| Aug 12, 2026 | Results · Other events ↗ |
| Jun 17, 2026 | Shareholder vote ↗ |
| Jun 8, 2026 | Other events ↗ |
| May 11, 2026 | Results · Other events ↗ |
| Mar 5, 2026 | Results ↗ |
| Jan 9, 2026 | Regulation FD ↗ |
| Nov 3, 2025 | Results ↗ |
| Oct 30, 2025 | Material agreement ↗ |
| Aug 12, 2025 | Results ↗ |